Duncker Streett & Co’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-515
| Closed | -$47.7K | – | 499 |
|
|
2024
Q2 | $47.7K | Hold |
515
| – | – | 0.01% | 320 |
|
|
2024
Q1 | $48.9K | Hold |
515
| – | – | 0.01% | 320 |
|
|
2023
Q4 | $46K | Buy |
515
+15
| +3% | +$1.34K | 0.01% | 319 |
|
|
2023
Q3 | $36.5K | Hold |
500
| – | – | 0.01% | 323 |
|
|
2023
Q2 | $41.6K | Hold |
500
| – | – | 0.01% | 314 |
|
|
2023
Q1 | $38.1K | Hold |
500
| – | – | 0.01% | 316 |
|
|
2022
Q4 | $41.5K | Buy |
+500
| New | +$41.5K | 0.01% | 311 |
|
|
2022
Q1 | – | Sell |
-301
| Closed | -$34K | – | 526 |
|
|
2021
Q4 | $34K | Hold |
301
| – | – | 0.01% | 370 |
|
|
2021
Q3 | $38K | Hold |
301
| – | – | 0.01% | 357 |
|
|
2021
Q2 | $41K | Hold |
301
| – | – | 0.01% | 353 |
|
|
2021
Q1 | $41K | Hold |
301
| – | – | 0.01% | 351 |
|
|
2020
Q4 | $42K | Buy |
+301
| New | +$42K | 0.01% | 352 |
|
|
2019
Q3 | – | Sell |
-300
| Closed | -$26K | – | 513 |
|
|
2019
Q2 | $26K | Hold |
300
| – | – | 0.01% | 427 |
|
|
2019
Q1 | $27K | Hold |
300
| – | – | 0.01% | 425 |
|
|
2018
Q4 | $22K | Hold |
300
| – | – | 0.01% | 433 |
|
|
2018
Q3 | $29K | Hold |
300
| – | – | 0.01% | 434 |
|
|
2018
Q2 | $29K | Buy |
+300
| New | +$29K | 0.01% | 432 |
|